These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 4209883

  • 1. Synthesis of von Willebrand factor by cultured human endothelial cells.
    Jaffe EA, Hoyer LW, Nachman RL.
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1906-9. PubMed ID: 4209883
    [Abstract] [Full Text] [Related]

  • 2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 3. The platelet-endothelial cell--VIII axis.
    Nachman RL, Jaffe EA.
    Thromb Haemost; 1976 Feb 29; 35(1):120-3. PubMed ID: 1085499
    [Abstract] [Full Text] [Related]

  • 4. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D, Potter EV.
    J Lab Clin Med; 1976 Jun 29; 87(6):976-86. PubMed ID: 778313
    [Abstract] [Full Text] [Related]

  • 5. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov 29; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.
    Nachman R, Levine R, Jaffe EA.
    J Clin Invest; 1977 Oct 29; 60(4):914-21. PubMed ID: 70434
    [Abstract] [Full Text] [Related]

  • 7. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE, Stratton RD, Wagner RH, Brinkhous KM.
    Proc Natl Acad Sci U S A; 1974 Aug 29; 71(8):2937-41. PubMed ID: 4547258
    [Abstract] [Full Text] [Related]

  • 8. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM, Zimmerman TS.
    J Clin Invest; 1980 Jun 29; 65(6):1318-25. PubMed ID: 6773982
    [Abstract] [Full Text] [Related]

  • 9. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN, Wiegerinck Y, Sixma JJ, Van Mourik JA, Mochtar IA.
    Nat New Biol; 1972 Mar 29; 236(65):104-6. PubMed ID: 4112547
    [No Abstract] [Full Text] [Related]

  • 10. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Lüscher EF.
    J Clin Invest; 1976 Jan 29; 57(1):112-24. PubMed ID: 1081991
    [Abstract] [Full Text] [Related]

  • 11. Subcellular platelet factor VIII antigen and von Willebrand factor.
    Nachman RL, Jaffe EA.
    J Exp Med; 1975 May 01; 141(5):1101-13. PubMed ID: 1168691
    [Abstract] [Full Text] [Related]

  • 12. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P, Zwaginga JJ, de Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, de Groot PG, Sixma JJ.
    Thromb Haemost; 1990 Oct 22; 64(2):227-31. PubMed ID: 2125373
    [Abstract] [Full Text] [Related]

  • 13. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 14. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y, Simeon J, Caen JP.
    J Lab Clin Med; 1976 Feb 11; 87(2):185-94. PubMed ID: 1082003
    [Abstract] [Full Text] [Related]

  • 15. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS.
    N Engl J Med; 1980 May 08; 302(19):1047-51. PubMed ID: 6767976
    [Abstract] [Full Text] [Related]

  • 16. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR, Coller BS, Sultan Y.
    J Clin Invest; 1975 Oct 08; 56(4):814-27. PubMed ID: 1080491
    [Abstract] [Full Text] [Related]

  • 17. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M.
    Diabetologia; 1982 Nov 08; 23(5):452-5. PubMed ID: 6816652
    [Abstract] [Full Text] [Related]

  • 18. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Nov 08; 113(5):670-84. PubMed ID: 2435633
    [Abstract] [Full Text] [Related]

  • 19. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H, Alter AA, Walker MR, Stefanyshyn M, Scott L, Miotti AB.
    J Lab Clin Med; 1976 Jul 08; 88(1):14-21. PubMed ID: 180215
    [Abstract] [Full Text] [Related]

  • 20. Von Willebrand's disease.
    Zimmerman TS, Ruggeri ZM.
    Prog Hemost Thromb; 1982 Jul 08; 6():203-36. PubMed ID: 6820163
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.